These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 15855212

  • 1. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL.
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [Abstract] [Full Text] [Related]

  • 2. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Jul; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 3. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 4. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM.
    Blood Purif; 2010 Jun; 29(2):191-6. PubMed ID: 20093826
    [Abstract] [Full Text] [Related]

  • 5. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 6. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
    Gattas DJ, Rajbhandari D, Bradford C, Buhr H, Lo S, Bellomo R.
    Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
    [Abstract] [Full Text] [Related]

  • 7. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 8. Conventional coagulation and thromboelastograph parameters and longevity of continuous renal replacement circuits.
    Holt AW, Bierer P, Glover P, Plummer JL, Bersten AD.
    Intensive Care Med; 2002 Nov; 28(11):1649-55. PubMed ID: 12415456
    [Abstract] [Full Text] [Related]

  • 9. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE.
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [Abstract] [Full Text] [Related]

  • 10. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA, Lilien M, van Kessel IA, Veldhoen ES, Wösten-van Asperen RM, van Gestel JPJ.
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [Abstract] [Full Text] [Related]

  • 11. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry.
    Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL.
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):732-8. PubMed ID: 17699489
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy.
    Liao YJ, Zhang L, Zeng XX, Fu P.
    Chin Med J (Engl); 2013 Apr; 126(7):1344-9. PubMed ID: 23557569
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
    Nagarik AP, Soni SS, Adikey GK, Raman A.
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
    [Abstract] [Full Text] [Related]

  • 16. Filter Size Not the Anticoagulation Method is the Decisive Factor in Continuous Renal Replacement Therapy Circuit Survival.
    Miklaszewska M, Korohoda P, Zachwieja K, Kobylarz K, Stefanidis CJ, Sobczak A, Drożdż D.
    Kidney Blood Press Res; 2017 May; 42(2):327-337. PubMed ID: 28578343
    [Abstract] [Full Text] [Related]

  • 17. Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice.
    Tovey L, Dickie H, Gangi S, Terblanche M, McKenzie C, Beale R, Treacher D, Ostermann M.
    Nephron Clin Pract; 2013 May; 124(1-2):119-23. PubMed ID: 24281234
    [Abstract] [Full Text] [Related]

  • 18. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?
    Agarwal B, Shaw S, Shankar Hari M, Burroughs AK, Davenport A.
    J Hepatol; 2009 Sep; 51(3):504-9. PubMed ID: 19615775
    [Abstract] [Full Text] [Related]

  • 19. Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure.
    Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desai MS, Braun MC, Akcan Arikan A.
    PLoS One; 2017 Sep; 12(8):e0182134. PubMed ID: 28792509
    [Abstract] [Full Text] [Related]

  • 20. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S, Pistolesi V, Cibelli L, Pierucci A.
    G Ital Nefrol; 2009 Sep; 26(1):13-21. PubMed ID: 19255959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.